Overview
Maria Caligo practices in Pisa, Italy. Caligo is rated as an Advanced expert by MediFind in the treatment of Ciliary Dyskinesia-Bronchiectasis. Their top areas of expertise are Ring Chromosome 6, Familial Isolated Hyperparathyroidism, Breast Cancer, and Milk-Alkali Syndrome.
Their clinical research consists of co-authoring 145 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Ciliary Dyskinesia-Bronchiectasis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Blepharophimosis SyndromeCaligo isAdvanced. Learn about Blepharophimosis Syndrome.
- Breast CancerCaligo isAdvanced. Learn about Breast Cancer.
- Breast Cancer in MenCaligo isAdvanced. Learn about Breast Cancer in Men.
- Ciliary Dyskinesia-Bronchiectasis
- DextrocardiaCaligo isAdvanced. Learn about Dextrocardia.
- Dextrocardia with Situs Inversus
- Experienced
- BlepharophimosisCaligo isExperienced. Learn about Blepharophimosis.
- BronchiectasisCaligo isExperienced. Learn about Bronchiectasis.
- CalcinosisCaligo isExperienced. Learn about Calcinosis.
- Dilated Cardiomyopathy (DCM)Caligo isExperienced. Learn about Dilated Cardiomyopathy (DCM).
- Drug Induced DyskinesiaCaligo isExperienced. Learn about Drug Induced Dyskinesia.
- Familial Prostate CancerCaligo isExperienced. Learn about Familial Prostate Cancer.